Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24371342 | 0.81 | MEN1 (0.49) | MEN1KMT2ALMNAALDH1A1MAPT | |
| SCHEMBL8910071 | 0.80 | TSHR (0.60) | TSHRMEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL31288539 | 0.78 | TSHR (0.54) | TSHRMEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL31485042 | 0.73 | MEN1 (0.47) | TSHRMEN1KMT2AALDH1A1MAPT | |
| Ether SCHEMBL5208110 | 0.73 | MEN1 (0.50) | TSHRMEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL11318101 | 0.72 | TSHR (0.47) | TSHRMEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL19220415 | 0.70 | LTA4H (0.57) | MEN1KMT2ALMNAMAPTSMN1; SMN2 | |
| SCHEMBL894135 | 0.70 | MEN1 (0.65) | TSHRMEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL11127924 | 0.69 | TSHR (0.47) | TSHRMEN1KMT2AALDH1A1ACHE | |
| SCHEMBL28634213 | 0.69 | MEN1 (0.43) | MEN1KMT2ALMNAALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042873-A1 | POLYMER BRUSHES WITH CHAIN-ENDS FUNCTIONALIZED WITH METAL COORDINATING TWO HETERO ELEMENTS FOR SELECTIVE SURFACE MODIFICATION | MERCK PATENT GMBH (DE) | 2026-02-12 | — | — | US | disclosed |
| EP-4573134-A2 | POLYMER BRUSHES WITH CHAIN-ENDS FUNCTIONALIZED WITH METAL COORDINATING TWO HETERO ELEMENTS FOR SELECTIVE SURFACE MODIFICATION | Merck Patent GmbH (DE) | 2025-06-25 | — | — | EP | disclosed |
| WO-2024038035-A2 | POLYMER BRUSHES WITH CHAIN-ENDS FUNCTIONALIZED WITH METAL COORDINATING TWO HETERO ELEMENTS FOR SELECTIVE SURFACE MODIFICATION | MERCK PATENT GMBH (DE) | 2024-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042873-A1 | POLYMER BRUSHES WITH CHAIN-ENDS FUNCTIONALIZED WITH METAL COORDINATING TWO HETERO ELEMENTS FOR SELECTIVE SURFACE MODIFICATION | VSIG8, PCBP1, PICALM | TSHR 1141/4885MEN1 3056/4885KMT2A 2500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.